Clinical trial

Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer

NCT07534033

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-12-06

PhasePHASE2

Study timeline

Study start (actual)2025-12-06Date precision: day

Registry last updated2026-04-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLC Diagnosed by Histology or Cytologyunresolved

A Multidisciplinary Team Assessment Determined That the Patient Was a Suitable Candidate for Radical Surgical Resectionunresolved

Overall Lung Function is Adequate for the Planned Lung Resectionunresolved

AJCC is Classified as IB-IIICunresolved

Interventions

Probiotics combined with neoadjuvant chemoimmunotherapyDRUG

Sponsors & collaborators

Zhujiang Hospitallead sponsor

Mapped research locations

GuangzhouChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07534033 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.